| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 1521 |
| 1 | METFORMIN | 1039 |
| 2 | METFORMIN ER 500 MG | 1001 |
| 3 | METFORMIN ER 750 MG | 1001 |
| 4 | ETANERCEPT | 680 |
| 5 | PALIPERIDONE PALMITATE | 521 |
| 6 | DUPILUMAB | 395 |
| 7 | EXENATIDE | 380 |
| 8 | LISINOPRIL | 338 |
| 9 | ASPIRIN | 332 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LENACAPAVIR SODIUM | 113 | 0.2233 |
| 1 | APOMORPHINE HYDROCHLORIDE | 101 | 0.0598 |
| 2 | DEOXYCHOLIC ACID | 123 | 0.0527 |
| 3 | MOTIXAFORTIDE | 5 | 0.0490 |
| 4 | SETMELANOTIDE | 13 | 0.0456 |
| 5 | CABOTEGRAVIR AND RILPIVIRINE | 203 | 0.0310 |
| 6 | CABOTEGRAVIR | 188 | 0.0229 |
| 7 | TOLCAPONE | 8 | 0.0227 |
| 8 | RILPIVIRINE | 158 | 0.0221 |
| 9 | PALIPERIDONE PALMITATE | 521 | 0.0159 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 745 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 672 |
| 2 | GLP-1 Receptor Agonist [EPC] | 620 |
| 3 | Insulin Analog [EPC] | 548 |
| 4 | Sulfonylurea [EPC] | 460 |
| 5 | Interleukin-4 Receptor alpha Antagonist [EPC] | 395 |
| 6 | Vitamin C [EPC] | 355 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 340 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 308 |
| 9 | Corticosteroid [EPC] | 307 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytolytic Agent [EPC] | 123 | 0.0527 |
| 1 | Melanocortin 4 Receptor Agonist [EPC] | 13 | 0.0456 |
| 2 | Antithrombin-directed RNA Interaction [EPC] | 1 | 0.0179 |
| 3 | Provitamin D2 Compound [EPC] | 286 | 0.0096 |
| 4 | Amino Acid Hypertonic Solution [EPC] | 1 | 0.0063 |
| 5 | Small Interfering RNA [EPC] | 1 | 0.0063 |
| 6 | Interleukin-5 Antagonist [EPC] | 4 | 0.0058 |
| 7 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 41 | 0.0040 |
| 8 | Sulfonylurea [EPC] | 460 | 0.0037 |
| 9 | CD4-directed Blocking Antibody [EPC] | 2 | 0.0037 |